Vivek Subbiah, MD

Articles by Vivek Subbiah, MD

Overview of SCLC and Importance of Early Diagnosis

ByCharu Aggarwal, MD, MPH,Taofeek K. Owonikoko, MD, PhD,Charles M. Rudin, MD, PhD,Vivek Subbiah, MD,Jared Weiss, MD

June 27th 2022

Drs Owonikoko and Weiss provide a brief overview of small cell lung cancer and the vital importance of an early diagnosis to improve patient outcomes.

Vivek Subbiah, MD, discusses outcomes with selpercatinib in patients with RET fusion–positive cancer.

Dr. Subbiah on the Efficacy of Selpercatinib in RET Fusion–Positive Cancers

ByVivek Subbiah, MD

April 13th 2021

Vivek Subbiah, MD, discusses outcomes with selpercatinib in patients with RET fusion–positive cancer.

Vivek Subbiah, MD

Articles by Vivek Subbiah, MD

Overview of SCLC and Importance of Early Diagnosis

Dr. Subbiah on the Efficacy of Selpercatinib in RET Fusion–Positive Cancers

Trending on OncLive

Epcoritamab Plus Lenalidomide/Rituximab Win EU Approval for R/R Follicular Lymphoma

Adagrasib Plus Cetuximab Misses OS, PFS End Points in Pretreated KRAS G12C–Mutated CRC

Phase 1 Data Highlight Potential Utility for In Vivo CAR T-Cell Therapy in R/R Myeloma

FDA Issues CRL to Orviglance for Liver Metastasis Imaging in Patients With Severe Kidney Impairment

AI Finds New Applications in Oncologic Surgery, Drug and Biomarker Screening, and Clinical Trial Design